241 related articles for article (PubMed ID: 17121429)
1. Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17beta-oestradiol in MCF7 human breast cancer cells.
Pugazhendhi D; Sadler AJ; Darbre PD
J Appl Toxicol; 2007; 27(1):67-77. PubMed ID: 17121429
[TBL] [Abstract][Full Text] [Related]
2. Oestrogenic activity of p-hydroxybenzoic acid (common metabolite of paraben esters) and methylparaben in human breast cancer cell lines.
Pugazhendhi D; Pope GS; Darbre PD
J Appl Toxicol; 2005; 25(4):301-9. PubMed ID: 16021681
[TBL] [Abstract][Full Text] [Related]
3. Oestrogenic activity of isobutylparaben in vitro and in vivo.
Darbre PD; Byford JR; Shaw LE; Horton RA; Pope GS; Sauer MJ
J Appl Toxicol; 2002; 22(4):219-26. PubMed ID: 12210538
[TBL] [Abstract][Full Text] [Related]
4. Oestrogenic activity of benzylparaben.
Darbre PD; Byford JR; Shaw LE; Hall S; Coldham NG; Pope GS; Sauer MJ
J Appl Toxicol; 2003; 23(1):43-51. PubMed ID: 12518336
[TBL] [Abstract][Full Text] [Related]
5. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
6. Oestrogenic activity of benzyl salicylate, benzyl benzoate and butylphenylmethylpropional (Lilial) in MCF7 human breast cancer cells in vitro.
Charles AK; Darbre PD
J Appl Toxicol; 2009 Jul; 29(5):422-34. PubMed ID: 19338011
[TBL] [Abstract][Full Text] [Related]
7. Oestrogenic activity of parabens in MCF7 human breast cancer cells.
Byford JR; Shaw LE; Drew MG; Pope GS; Sauer MJ; Darbre PD
J Steroid Biochem Mol Biol; 2002 Jan; 80(1):49-60. PubMed ID: 11867263
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.
Matsumura A; Ghosh A; Pope GS; Darbre PD
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):431-43. PubMed ID: 15876408
[TBL] [Abstract][Full Text] [Related]
9. Significance of the detection of esters of p-hydroxybenzoic acid (parabens) in human breast tumours.
Harvey PW; Everett DJ
J Appl Toxicol; 2004; 24(1):1-4. PubMed ID: 14745840
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of methyl-, butyl- and propylparaben and 17β-estradiol on selected cell cycle and apoptosis gene and protein expression in MCF-7 breast cancer cells and MCF-10A non-malignant cells.
Wróbel AM; Gregoraszczuk EŁ
J Appl Toxicol; 2014 Sep; 34(9):1041-50. PubMed ID: 24481588
[TBL] [Abstract][Full Text] [Related]
11. Exposure to parabens at the concentration of maximal proliferative response increases migratory and invasive activity of human breast cancer cells in vitro.
Khanna S; Dash PR; Darbre PD
J Appl Toxicol; 2014 Sep; 34(9):1051-9. PubMed ID: 24652746
[TBL] [Abstract][Full Text] [Related]
12. Oestrogenic and androgenic activity of triclosan in breast cancer cells.
Gee RH; Charles A; Taylor N; Darbre PD
J Appl Toxicol; 2008 Jan; 28(1):78-91. PubMed ID: 17992702
[TBL] [Abstract][Full Text] [Related]
13. The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles.
Cunliffe HE; Ringnér M; Bilke S; Walker RL; Cheung JM; Chen Y; Meltzer PS
Cancer Res; 2003 Nov; 63(21):7158-66. PubMed ID: 14612509
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7.
Leung LK; Wang TT
Br J Cancer; 1999 Oct; 81(3):387-92. PubMed ID: 10507761
[TBL] [Abstract][Full Text] [Related]
15. Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells.
Buterin T; Koch C; Naegeli H
Carcinogenesis; 2006 Aug; 27(8):1567-78. PubMed ID: 16474171
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of parabens in human breast tumours.
Darbre PD; Aljarrah A; Miller WR; Coldham NG; Sauer MJ; Pope GS
J Appl Toxicol; 2004; 24(1):5-13. PubMed ID: 14745841
[TBL] [Abstract][Full Text] [Related]
17. Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells.
Liu S; Stromberg A; Tai HH; Moscow JA
Mol Cancer Res; 2004 Aug; 2(8):477-87. PubMed ID: 15328374
[TBL] [Abstract][Full Text] [Related]
18. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
[TBL] [Abstract][Full Text] [Related]
19. Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells.
Rasmussen LM; Frederiksen KS; Din N; Galsgaard E; Christensen L; Berchtold MW; Panina S
Endocr Relat Cancer; 2010 Sep; 17(3):809-22. PubMed ID: 20601496
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling of estrogen-responsive genes in breast cancer cells treated with alkylphenols, chlorinated phenols, parabens, or bis- and benzoylphenols for evaluation of estrogenic activity.
Terasaka S; Inoue A; Tanji M; Kiyama R
Toxicol Lett; 2006 May; 163(2):130-41. PubMed ID: 16280211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
